
AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications
Keywords: Recombinant virus; Optimization; AAV; AAV2-GFP; Polyethylenimine (PEI); N/P ratio;